Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nobelpharma

This article was originally published in The Gray Sheet

Executive Summary

Will appeal jury verdict on litigation involving Implant Innovations, Inc. (3i) that it fraudulently obtained a patent regarding surface technology on titanium dental implants ("The Gray Sheet" May 16, I&W-9). Nobelpharma "strongly believes that the verdict is wrong, and that it is the result of erroneous rulings made by the Court, including rulings that precluded several of Nobelpharma's witnesses from testifying." The firm notes that in January 1989 Core-Vent signed a consent decree asserting the validity of the same patent at issue in the 3i case. Additional litigation is ongoing between Core-Vent and Nobelpharma, Core-Vent says...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002402

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel